Trial Profile
Study of alipogen tiparvovec [Glybera] in patients with hyperlipoproteinaemia type I
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 13 Apr 2015
Price :
$35
*
At a glance
- Drugs Alipogene tiparvovec (Primary)
- Indications Hyperlipoproteinaemia type I
- Focus Adverse reactions; Therapeutic Use
- Sponsors uniQure
- 13 Apr 2015 New trial record